Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 893401, 8 pages
http://dx.doi.org/10.1155/2010/893401
Research Article

Effect of Combination Therapy with Sodium Ozagrel and Panax Ginseng on Transient Cerebral Ischemia Model in Rats

1Institute of Catholic Integrative Medicine (ICIM), Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon 403-720, Republic of Korea
2Department of Neruosurgery, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea

Received 8 November 2010; Accepted 8 December 2010

Academic Editor: Thomas Van Groen

Copyright © 2010 Sang In Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. M. Klijn and G. J. Hankey, “Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative,” Lancet Neurology, vol. 2, no. 11, pp. 698–701, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. W. Fawcett and R. A. Asher, “The glial scar and central nervous system repair,” Brain Research Bulletin, vol. 49, no. 6, pp. 377–391, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Silver and J. H. Miller, “Regeneration beyond the glial scar,” Nature Reviews Neuroscience, vol. 5, no. 2, pp. 146–156, 2004. View at Google Scholar · View at Scopus
  4. Q. Wang, A. Y. Sun, A. Simonyi et al., “Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS,” Free Radical Biology and Medicine, vol. 43, no. 7, pp. 1048–1060, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. J. M. Mulvey, N. W. C. Dorsch, Y. Mudaliar, and E. W. Lang, “Multimodality monitoring in severe traumatic brain injury: the role of brain tissue oxygenation monitoring,” Neurocritical Care, vol. 1, no. 3, pp. 391–402, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Arii, H. Igarashi, T. Arii, and Y. Katayama, “The effect of ozagrel sodium on photochemical thrombosis in rat: therapeutic window and combined therapy with heparin sodium,” Life Sciences, vol. 71, no. 25, pp. 2983–2994, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Imamura, S. Kiguchi, K. Kobayashi, K. Ichikawa, Y. Yamazaki, and M. Kojima, “Effect of ozagrel, a selective thromboxane A2-synthetase inhibitor, on cerebral infarction in rats. Comparative study with norphenazone, a free-radical scavenger,” Arzneimittel-Forschung, vol. 53, no. 10, pp. 688–694, 2003. View at Google Scholar · View at Scopus
  8. H. Komatsu, Y. Takehana, and S. Hamano, “Beneficial effect of OKY-046, a selective thromboxane A synthetase inhibitor, on experimental cerebral vasospasm,” Japanese Journal of Pharmacology, vol. 41, no. 3, pp. 381–391, 1986. View at Google Scholar · View at Scopus
  9. S. Suzuki, K. Sano, H. Handa et al., “Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study,” Neurological Research, vol. 11, no. 2, pp. 79–88, 1989. View at Google Scholar · View at Scopus
  10. T. Yoshikawa, Y. Akiyoshi, T. Susumu et al., “Ginsenoside Rb reduces neurodegeneration in the peri-infarct area of a thromboembolic stroke model in non-human primates,” Journal of Pharmacological Sciences, vol. 107, no. 1, pp. 32–40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Bu, Z. H. Jin, S. Y. Park et al., “Siberian ginseng reduces infarct volume in transient focal cerebral ischaemia in Sprague-Dawley rats,” Phytotherapy Research, vol. 19, no. 2, pp. 167–169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Y. Son, H. S. Han, H. W. Jung, and Y. K. Park, “Panax notoginseng attenuates the infarct volume in rat ischemic brain and the inflammatory response of microglia,” Journal of Pharmacological Sciences, vol. 109, no. 3, pp. 368–379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. D. W. Kaufman, J. P. Kelly, L. Rosenberg, T. E. Anderson, and A. A. Mitchell, “Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey,” Journal of the American Medical Association, vol. 287, no. 3, pp. 337–344, 2002. View at Google Scholar · View at Scopus
  14. Y. O. Kim, H. J. Kim, G. S. Kim et al., “Panax ginseng protects against global ischemia injury in rat hippocampus,” Journal of Medicinal Food, vol. 12, no. 1, pp. 71–76, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Z. Longa, P. R. Weinstein, S. Carlson, and R. Cummins, “Reversible middle cerebral artery occlusion without craniectomy in rats,” Stroke, vol. 20, no. 1, pp. 84–91, 1989. View at Google Scholar · View at Scopus
  16. K. Radad, G. Gille, L. Liu, and W. D. Rausch, “Use of ginseng in medicine with emphasis on neurodegenerative disorders,” Journal of Pharmacological Sciences, vol. 100, no. 3, pp. 175–186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Y. Han, H. X. Li, C. C. Bai, L. Wang, and P. F. Tu, “Component analysis and free radical-scavenging potential of Panax notoginseng and Carthamus tinctorius extracts,” Chemistry and Biodiversity, vol. 7, no. 2, pp. 383–391, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Tian, F. Fu, M. Geng et al., “Neuroprotective effect of 20(S)-ginsenoside Rg on cerebral ischemia in rats,” Neuroscience Letters, vol. 374, no. 2, pp. 92–97, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Ye, N. Li, J. Han et al., “Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons,” Neuroscience Research, vol. 64, no. 3, pp. 306–310, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Collombet, C. Masqueliez, E. Four et al., “Early reduction of NeuN antigenicity induced by soman poisoning in mice can be used to predict delayed neuronal degeneration in the hippocampus,” Neuroscience Letters, vol. 398, no. 3, pp. 337–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. D. J. Cole, P. M. Patel, R. M. Schell, J. C. Drummond, and T. N. Osborne, “Brain eicosanoid levels during temporary focal cerebral ischemia in rats: a microdialysis study,” Journal of Neurosurgical Anesthesiology, vol. 5, no. 1, pp. 41–47, 1993. View at Google Scholar · View at Scopus
  22. A. J. Grau, A. Ruf, A. Vogt et al., “Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia,” Thrombosis and Haemostasis, vol. 80, no. 2, pp. 298–301, 1998. View at Google Scholar · View at Scopus
  23. F. Van Kooten, G. Ciabattoni, C. Patrono, P. I. M. Schmitz, J. Van Gijn, and P. J. Koudstaal, “Evidence for episodic platelet activation in acute ischemic stroke,” Stroke, vol. 25, no. 2, pp. 278–281, 1994. View at Google Scholar · View at Scopus
  24. N. Heye and J. Cervós-Navarro, “Microthromboemboli in acute infarcts: analysis of 40 autopsy cases,” Stroke, vol. 27, no. 3, pp. 431–434, 1996. View at Google Scholar · View at Scopus